ATOS Stock 1.46 Atossa Genetics Inc $ATOS Hit 21 52 week

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...

Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...

BAE Systems Achieves Key Contract with U.S. Marine Corps BAE Systems has successfully secured a substantial contract valued at $188 million from the U.S. Marine Corps for the full-rate production of 30 Amphibious Combat Vehicle 30mm (ACV-30) units. This notable contract encompasses not only the vehicles themselves but also vital fielding support, spare parts, and...

Exciting Developments with YesWelder's Firstess DP200 As the buzz intensifies around YesWelder's innovative Firstess DP200, time is running out for enthusiasts to seize this remarkable opportunity. The recent Kickstarter campaign has created a remarkable buzz, gathering the attention of welders from various backgrounds, and it is set to conclude in just a few days. A...

Lifecore Biomedical's Strategic Stock Grants for New Leader Lifecore Biomedical, Inc. (NASDAQ: LFCR) is making headlines with its recent employee incentives geared towards attracting top talent. This fully integrated contract development and manufacturing organization (CDMO) has announced a substantial inducement package for its newly appointed chief legal and...

Decoding Recent Options Activity for Centene Investors are seeing a notable shift in the options landscape surrounding Centene (CNC). Deep-pocketed investors have expressed a bearish sentiment, indicating potential undercurrents that market players should pay close attention to. This heightened activity comes as no surprise to those following public options records, which...

Extu Achieves Prestigious Gold Award Extu, a notable player in channel marketing, has made headlines by winning a gold award at the MarCom Awards for its impressive brand redesign. This achievement highlights the company's dedication to enhancing its branding and strategic communication efforts. Understanding the MarCom Awards The MarCom Awards are recognized globally...